These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10451710)

  • 21. Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.
    Yang FC; Ingram DA; Chen S; Zhu Y; Yuan J; Li X; Yang X; Knowles S; Horn W; Li Y; Zhang S; Yang Y; Vakili ST; Yu M; Burns D; Robertson K; Hutchins G; Parada LF; Clapp DW
    Cell; 2008 Oct; 135(3):437-48. PubMed ID: 18984156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas.
    Serra E; Puig S; Otero D; Gaona A; Kruyer H; Ars E; Estivill X; Lázaro C
    Am J Hum Genet; 1997 Sep; 61(3):512-9. PubMed ID: 9326316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD44 expression is aberrant in benign Schwann cell tumors possessing mutations in the neurofibromatosis type 2, but not type 1, gene.
    Sherman L; Jacoby LB; Lampe J; Pelton P; Aguzzi A; Herrlich P; Ponta H
    Cancer Res; 1997 Nov; 57(21):4889-97. PubMed ID: 9354454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis.
    Luscan A; Shackleford G; Masliah-Planchon J; Laurendeau I; Ortonne N; Varin J; Lallemand F; Leroy K; Dumaine V; Hivelin M; Borderie D; De Raedt T; Valeyrie-Allanore L; Larousserie F; Terris B; Lantieri L; Vidaud M; Vidaud D; Wolkenstein P; Parfait B; Bièche I; Massaad C; Pasmant E
    Clin Cancer Res; 2014 Jan; 20(2):358-71. PubMed ID: 24218515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microsatellite instability and promoter methylation as possible causes of NF1 gene inactivation in neurofibromas.
    Luijten M; Redeker S; van Noesel MM; Troost D; Westerveld A; Hulsebos TJ
    Eur J Hum Genet; 2000 Dec; 8(12):939-45. PubMed ID: 11175282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoamide Inhibits NF1 Deficiency-induced Epithelial-Mesenchymal Transition in Murine Schwann Cells.
    Zhang Y; Zhou R; Qu Y; Shu M; Guo S; Bai Z
    Arch Med Res; 2017 Aug; 48(6):498-505. PubMed ID: 29198560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden.
    Thomas L; Kluwe L; Chuzhanova N; Mautner V; Upadhyaya M
    Neurogenetics; 2010 Oct; 11(4):391-400. PubMed ID: 20358387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of somatic NF1 promoter methylation in plexiform neurofibromas and Schwann cells.
    Fishbein L; Eady B; Sanek N; Muir D; Wallace MR
    Cancer Genet Cytogenet; 2005 Mar; 157(2):181-6. PubMed ID: 15721644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic loss of wild type NF1 allele in neurofibromas: Comparison of NF1 microdeletion and non-microdeletion patients.
    De Raedt T; Maertens O; Chmara M; Brems H; Heyns I; Sciot R; Majounie E; Upadhyaya M; De Schepper S; Speleman F; Messiaen L; Vermeesch JR; Legius E
    Genes Chromosomes Cancer; 2006 Oct; 45(10):893-904. PubMed ID: 16830335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does Schwann cell dedifferentiation originate dermal neurofibromas?
    Iribar H; Jaka A; Ormaechea N; Tuneu A; Izeta A; Gutiérrez-Rivera A
    Exp Dermatol; 2016 Nov; 25(11):901-903. PubMed ID: 27303947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiogenic and invasive properties of neurofibroma Schwann cells.
    Sheela S; Riccardi VM; Ratner N
    J Cell Biol; 1990 Aug; 111(2):645-53. PubMed ID: 1696266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene.
    Däschner K; Assum G; Eisenbarth I; Krone W; Hoffmeyer S; Wortmann S; Heymer B; Kehrer-Sawatzki H
    Biochem Biophys Res Commun; 1997 May; 234(2):346-50. PubMed ID: 9177273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells.
    Yang FC; Ingram DA; Chen S; Hingtgen CM; Ratner N; Monk KR; Clegg T; White H; Mead L; Wenning MJ; Williams DA; Kapur R; Atkinson SJ; Clapp DW
    J Clin Invest; 2003 Dec; 112(12):1851-61. PubMed ID: 14679180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.
    Le LQ; Liu C; Shipman T; Chen Z; Suter U; Parada LF
    Cancer Res; 2011 Jul; 71(13):4686-95. PubMed ID: 21551250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NF1 patient missense variants predict a role for ATM in modifying neurofibroma initiation.
    Yu Y; Choi K; Wu J; Andreassen PR; Dexheimer PJ; Keddache M; Brems H; Spinner RJ; Cancelas JA; Martin LJ; Wallace MR; Legius E; Vogel KS; Ratner N
    Acta Neuropathol; 2020 Jan; 139(1):157-174. PubMed ID: 31664505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Culture of cytogenetically abnormal schwann cells from benign and malignant NF1 tumors.
    Wallace MR; Rasmussen SA; Lim IT; Gray BA; Zori RT; Muir D
    Genes Chromosomes Cancer; 2000 Feb; 27(2):117-23. PubMed ID: 10612798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schwann cells from human neurofibromas show increased proliferation rates under the influence of progesterone.
    Overdiek A; Winner U; Mayatepek E; Rosenbaum T
    Pediatr Res; 2008 Jul; 64(1):40-3. PubMed ID: 18360307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts.
    Atit RP; Crowe MJ; Greenhalgh DG; Wenstrup RJ; Ratner N
    J Invest Dermatol; 1999 Jun; 112(6):835-42. PubMed ID: 10383727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.
    Yang FC; Chen S; Clegg T; Li X; Morgan T; Estwick SA; Yuan J; Khalaf W; Burgin S; Travers J; Parada LF; Ingram DA; Clapp DW
    Hum Mol Genet; 2006 Aug; 15(16):2421-37. PubMed ID: 16835260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas.
    Steinmann K; Kluwe L; Friedrich RE; Mautner VF; Cooper DN; Kehrer-Sawatzki H
    J Invest Dermatol; 2009 Mar; 129(3):615-21. PubMed ID: 18800150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.